Global Peripheral Vasodilator Drugs Supply, Demand and Key Producers, 2025-2031
Page: 150
Published Date: 20 Oct 2025
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
Description 
Table of Contents 
Table of Figures 
Research Methodology 
Companies Mentioned 
Related Reports 
Product Tags
Table of Contents 
Table of Figures 
Research Methodology 
Companies Mentioned 
Related Reports 
Product Tags 
Description
The global Peripheral Vasodilator Drugs market size is expected to reach $ 9119 million by 2031, rising at a market growth of 5.2% CAGR during the forecast period (2025-2031).
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Peripheral Vasodilator Drugs
The global Peripheral Vasodilator Drugs market size is expected to reach $ 9119 million by 2031, rising at a market growth of 5.2% CAGR during the forecast period (2025-2031).
Unit: US$ M
www.globalinforesearch.com
Business Risk & Industry Analysis Reports
Peripheral vasodilator drugs are a class of medications used to treat conditions related to the constriction of blood vessels in the peripheral tissues of the body. These drugs work by relaxing the smooth muscles in the walls of blood vessels.
Increase in prevalence of hypertension and other cardiovascular diseases is a major factor driving the global peripheral vasodilator drugs market, As these conditions become more common, demand for effective treatments is lilkely to rise, thus driving innovation and development in the peripheral vasodilator drugs industry. According to the World Health Organization (WHO), hypertension affects around 1.13 billion people globally, and is a major cause of morbidity and mortality. peripheral vasodilator drugs play a key role in managing cardiovascular diseases by improving blood flow, reducing blood pressure, easing the heart’s workload, and alleviating symptoms of conditions like peripheral arterial disease. For example, in June 2024, the Australian Institute of Health and Welfare, an Australian government agency, reported that doctor-certified deaths from coronary heart disease (CHD) rose from 14,100 in 2021 to 14,900 in 2022. As such, the increasing prevalence of CVDs is contributing to the growth of the peripheral vasodilator drug market.
This report studies the global Peripheral Vasodilator Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Peripheral Vasodilator Drugs and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2024 as the base year. This report explores demand trends and competition, as well as details the characteristics of Peripheral Vasodilator Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Peripheral Vasodilator Drugs total production and demand, 2020-2031, (K Units)
Global Peripheral Vasodilator Drugs total production value, 2020-2031, (USD Million)
Global Peripheral Vasodilator Drugs production by region & country, production, value, CAGR, 2020-2031, (USD Million) & (K Units), (based on production site)
Global Peripheral Vasodilator Drugs consumption by region & country, CAGR, 2020-2031 & (K Units)
U.S. VS China: Peripheral Vasodilator Drugs domestic production, consumption, key domestic manufacturers and share
Global Peripheral Vasodilator Drugs production by manufacturer, production, price, value and market share 2020-2025, (USD Million) & (K Units)
Global Peripheral Vasodilator Drugs production by Type, production, value, CAGR, 2020-2031, (USD Million) & (K Units)
Global Peripheral Vasodilator Drugs production by Application, production, value, CAGR, 2020-2031, (USD Million) & (K Units)
This report profiles key players in the global Peripheral Vasodilator Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Inc., Novartis AG, GSK plc, AstraZeneca, Merck & Co., Inc., Sanofi, Bayer AG, Abbott Laboratories, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Peripheral Vasodilator Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2020-2031 by year with 2024 as the base year, 2025 as the estimate year, and 2026-2031 as the forecast year.
Global Peripheral Vasodilator Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Peripheral Vasodilator Drugs Market, Segmentation by Type:
Calcium Channel Blockers
Alpha-adrenergic Blockers
Potassium Channel Activators
Others
Global Peripheral Vasodilator Drugs Market, Segmentation by Indication:
Hypertension
Angina
Heart Failure
Others
Global Peripheral Vasodilator Drugs Market, Segmentation by Application:
Hospital
Retail Pharmacies
Others
Companies Profiled:
Pfizer, Inc.
Novartis AG
GSK plc
AstraZeneca
Merck & Co., Inc.
Sanofi
Bayer AG
Abbott Laboratories
Bristol-Myers Squibb Company
Boehringer Ingelheim International GmbH
Teva Pharmaceutical Industries Ltd.
Viatris, Inc.
Sun Pharmaceutical Industries Ltd.
Lupin
Aotecar Medical-B
Endovastec
Tibet Cheezheng Tibetan Medicine Co., Ltd
Bat Medical
Key Questions Answered:
1. How big is the global Peripheral Vasodilator Drugs market?
2. What is the demand of the global Peripheral Vasodilator Drugs market?
3. What is the year over year growth of the global Peripheral Vasodilator Drugs market?
4. What is the production and production value of the global Peripheral Vasodilator Drugs market?
5. Who are the key producers in the global Peripheral Vasodilator Drugs market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 Peripheral Vasodilator Drugs Introduction
1.2 World Peripheral Vasodilator Drugs Supply & Forecast
1.2.1 World Peripheral Vasodilator Drugs Production Value (2020 & 2024 & 2031)
1.2.2 World Peripheral Vasodilator Drugs Production (2020-2031)
1.2.3 World Peripheral Vasodilator Drugs Pricing Trends (2020-2031)
1.3 World Peripheral Vasodilator Drugs Production by Region (Based on Production Site)
1.3.1 World Peripheral Vasodilator Drugs Production Value by Region (2020-2031)
1.3.2 World Peripheral Vasodilator Drugs Production by Region (2020-2031)
1.3.3 World Peripheral Vasodilator Drugs Average Price by Region (2020-2031)
1.3.4 North America Peripheral Vasodilator Drugs Production (2020-2031)
1.3.5 Europe Peripheral Vasodilator Drugs Production (2020-2031)
1.3.6 China Peripheral Vasodilator Drugs Production (2020-2031)
1.3.7 Japan Peripheral Vasodilator Drugs Production (2020-2031)
1.4 Market Drivers, Restraints and Trends
1.4.1 Peripheral Vasodilator Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Peripheral Vasodilator Drugs Major Market Trends
2.1 World Peripheral Vasodilator Drugs Demand (2020-2031)
2.2 World Peripheral Vasodilator Drugs Consumption by Region
2.2.1 World Peripheral Vasodilator Drugs Consumption by Region (2020-2025)
2.2.2 World Peripheral Vasodilator Drugs Consumption Forecast by Region (2026-2031)
2.3 United States Peripheral Vasodilator Drugs Consumption (2020-2031)
2.4 China Peripheral Vasodilator Drugs Consumption (2020-2031)
2.5 Europe Peripheral Vasodilator Drugs Consumption (2020-2031)
2.6 Japan Peripheral Vasodilator Drugs Consumption (2020-2031)
2.7 South Korea Peripheral Vasodilator Drugs Consumption (2020-2031)
2.8 ASEAN Peripheral Vasodilator Drugs Consumption (2020-2031)
2.9 India Peripheral Vasodilator Drugs Consumption (2020-2031)
3.1 World Peripheral Vasodilator Drugs Production Value by Manufacturer (2020-2025)
3.2 World Peripheral Vasodilator Drugs Production by Manufacturer (2020-2025)
3.3 World Peripheral Vasodilator Drugs Average Price by Manufacturer (2020-2025)
3.4 Peripheral Vasodilator Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Peripheral Vasodilator Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Peripheral Vasodilator Drugs in 2024
3.5.3 Global Concentration Ratios (CR8) for Peripheral Vasodilator Drugs in 2024
3.6 Peripheral Vasodilator Drugs Market: Overall Company Footprint Analysis
3.6.1 Peripheral Vasodilator Drugs Market: Region Footprint
3.6.2 Peripheral Vasodilator Drugs Market: Company Product Type Footprint
3.6.3 Peripheral Vasodilator Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Peripheral Vasodilator Drugs Production Value Comparison
4.1.1 United States VS China: Peripheral Vasodilator Drugs Production Value Comparison (2020 & 2024 & 2031)
4.1.2 United States VS China: Peripheral Vasodilator Drugs Production Value Market Share Comparison (2020 & 2024 & 2031)
4.2 United States VS China: Peripheral Vasodilator Drugs Production Comparison
4.2.1 United States VS China: Peripheral Vasodilator Drugs Production Comparison (2020 & 2024 & 2031)
4.2.2 United States VS China: Peripheral Vasodilator Drugs Production Market Share Comparison (2020 & 2024 & 2031)
4.3 United States VS China: Peripheral Vasodilator Drugs Consumption Comparison
4.3.1 United States VS China: Peripheral Vasodilator Drugs Consumption Comparison (2020 & 2024 & 2031)
4.3.2 United States VS China: Peripheral Vasodilator Drugs Consumption Market Share Comparison (2020 & 2024 & 2031)
4.4 United States Based Peripheral Vasodilator Drugs Manufacturers and Market Share, 2020-2025
4.4.1 United States Based Peripheral Vasodilator Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Peripheral Vasodilator Drugs Production Value (2020-2025)
4.4.3 United States Based Manufacturers Peripheral Vasodilator Drugs Production (2020-2025)
4.5 China Based Peripheral Vasodilator Drugs Manufacturers and Market Share
4.5.1 China Based Peripheral Vasodilator Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Peripheral Vasodilator Drugs Production Value (2020-2025)
4.5.3 China Based Manufacturers Peripheral Vasodilator Drugs Production (2020-2025)
4.6 Rest of World Based Peripheral Vasodilator Drugs Manufacturers and Market Share, 2020-2025
4.6.1 Rest of World Based Peripheral Vasodilator Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Peripheral Vasodilator Drugs Production Value (2020-2025)
4.6.3 Rest of World Based Manufacturers Peripheral Vasodilator Drugs Production (2020-2025)
5.1 World Peripheral Vasodilator Drugs Market Size Overview by Type: 2020 VS 2024 VS 2031
5.2 Segment Introduction by Type
5.2.1 Calcium Channel Blockers
5.2.2 Alpha-adrenergic Blockers
5.2.3 Potassium Channel Activators
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Peripheral Vasodilator Drugs Production by Type (2020-2031)
5.3.2 World Peripheral Vasodilator Drugs Production Value by Type (2020-2031)
5.3.3 World Peripheral Vasodilator Drugs Average Price by Type (2020-2031)
6.1 World Peripheral Vasodilator Drugs Market Size Overview by Application: 2020 VS 2024 VS 2031
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Retail Pharmacies
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Peripheral Vasodilator Drugs Production by Application (2020-2031)
6.3.2 World Peripheral Vasodilator Drugs Production Value by Application (2020-2031)
6.3.3 World Peripheral Vasodilator Drugs Average Price by Application (2020-2031)
7.1 Pfizer, Inc.
7.1.1 Pfizer, Inc. Details
7.1.2 Pfizer, Inc. Major Business
7.1.3 Pfizer, Inc. Peripheral Vasodilator Drugs Product and Services
7.1.4 Pfizer, Inc. Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.1.5 Pfizer, Inc. Recent Developments/Updates
7.1.6 Pfizer, Inc. Competitive Strengths & Weaknesses
7.2 Novartis AG
7.2.1 Novartis AG Details
7.2.2 Novartis AG Major Business
7.2.3 Novartis AG Peripheral Vasodilator Drugs Product and Services
7.2.4 Novartis AG Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.2.5 Novartis AG Recent Developments/Updates
7.2.6 Novartis AG Competitive Strengths & Weaknesses
7.3 GSK plc
7.3.1 GSK plc Details
7.3.2 GSK plc Major Business
7.3.3 GSK plc Peripheral Vasodilator Drugs Product and Services
7.3.4 GSK plc Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.3.5 GSK plc Recent Developments/Updates
7.3.6 GSK plc Competitive Strengths & Weaknesses
7.4 AstraZeneca
7.4.1 AstraZeneca Details
7.4.2 AstraZeneca Major Business
7.4.3 AstraZeneca Peripheral Vasodilator Drugs Product and Services
7.4.4 AstraZeneca Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.4.5 AstraZeneca Recent Developments/Updates
7.4.6 AstraZeneca Competitive Strengths & Weaknesses
7.5 Merck & Co., Inc.
7.5.1 Merck & Co., Inc. Details
7.5.2 Merck & Co., Inc. Major Business
7.5.3 Merck & Co., Inc. Peripheral Vasodilator Drugs Product and Services
7.5.4 Merck & Co., Inc. Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.5.5 Merck & Co., Inc. Recent Developments/Updates
7.5.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
7.6 Sanofi
7.6.1 Sanofi Details
7.6.2 Sanofi Major Business
7.6.3 Sanofi Peripheral Vasodilator Drugs Product and Services
7.6.4 Sanofi Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.6.5 Sanofi Recent Developments/Updates
7.6.6 Sanofi Competitive Strengths & Weaknesses
7.7 Bayer AG
7.7.1 Bayer AG Details
7.7.2 Bayer AG Major Business
7.7.3 Bayer AG Peripheral Vasodilator Drugs Product and Services
7.7.4 Bayer AG Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.7.5 Bayer AG Recent Developments/Updates
7.7.6 Bayer AG Competitive Strengths & Weaknesses
7.8 Abbott Laboratories
7.8.1 Abbott Laboratories Details
7.8.2 Abbott Laboratories Major Business
7.8.3 Abbott Laboratories Peripheral Vasodilator Drugs Product and Services
7.8.4 Abbott Laboratories Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.8.5 Abbott Laboratories Recent Developments/Updates
7.8.6 Abbott Laboratories Competitive Strengths & Weaknesses
7.9 Bristol-Myers Squibb Company
7.9.1 Bristol-Myers Squibb Company Details
7.9.2 Bristol-Myers Squibb Company Major Business
7.9.3 Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Product and Services
7.9.4 Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.9.5 Bristol-Myers Squibb Company Recent Developments/Updates
7.9.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
7.10 Boehringer Ingelheim International GmbH
7.10.1 Boehringer Ingelheim International GmbH Details
7.10.2 Boehringer Ingelheim International GmbH Major Business
7.10.3 Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Product and Services
7.10.4 Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.10.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
7.10.6 Boehringer Ingelheim International GmbH Competitive Strengths & Weaknesses
7.11 Teva Pharmaceutical Industries Ltd.
7.11.1 Teva Pharmaceutical Industries Ltd. Details
7.11.2 Teva Pharmaceutical Industries Ltd. Major Business
7.11.3 Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product and Services
7.11.4 Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
7.11.6 Teva Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
7.12 Viatris, Inc.
7.12.1 Viatris, Inc. Details
7.12.2 Viatris, Inc. Major Business
7.12.3 Viatris, Inc. Peripheral Vasodilator Drugs Product and Services
7.12.4 Viatris, Inc. Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.12.5 Viatris, Inc. Recent Developments/Updates
7.12.6 Viatris, Inc. Competitive Strengths & Weaknesses
7.13 Sun Pharmaceutical Industries Ltd.
7.13.1 Sun Pharmaceutical Industries Ltd. Details
7.13.2 Sun Pharmaceutical Industries Ltd. Major Business
7.13.3 Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product and Services
7.13.4 Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.13.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
7.13.6 Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
7.14 Lupin
7.14.1 Lupin Details
7.14.2 Lupin Major Business
7.14.3 Lupin Peripheral Vasodilator Drugs Product and Services
7.14.4 Lupin Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.14.5 Lupin Recent Developments/Updates
7.14.6 Lupin Competitive Strengths & Weaknesses
7.15 Aotecar Medical-B
7.15.1 Aotecar Medical-B Details
7.15.2 Aotecar Medical-B Major Business
7.15.3 Aotecar Medical-B Peripheral Vasodilator Drugs Product and Services
7.15.4 Aotecar Medical-B Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.15.5 Aotecar Medical-B Recent Developments/Updates
7.15.6 Aotecar Medical-B Competitive Strengths & Weaknesses
7.16 Endovastec
7.16.1 Endovastec Details
7.16.2 Endovastec Major Business
7.16.3 Endovastec Peripheral Vasodilator Drugs Product and Services
7.16.4 Endovastec Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.16.5 Endovastec Recent Developments/Updates
7.16.6 Endovastec Competitive Strengths & Weaknesses
7.17 Tibet Cheezheng Tibetan Medicine Co., Ltd
7.17.1 Tibet Cheezheng Tibetan Medicine Co., Ltd Details
7.17.2 Tibet Cheezheng Tibetan Medicine Co., Ltd Major Business
7.17.3 Tibet Cheezheng Tibetan Medicine Co., Ltd Peripheral Vasodilator Drugs Product and Services
7.17.4 Tibet Cheezheng Tibetan Medicine Co., Ltd Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.17.5 Tibet Cheezheng Tibetan Medicine Co., Ltd Recent Developments/Updates
7.17.6 Tibet Cheezheng Tibetan Medicine Co., Ltd Competitive Strengths & Weaknesses
7.18 Bat Medical
7.18.1 Bat Medical Details
7.18.2 Bat Medical Major Business
7.18.3 Bat Medical Peripheral Vasodilator Drugs Product and Services
7.18.4 Bat Medical Peripheral Vasodilator Drugs Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.18.5 Bat Medical Recent Developments/Updates
7.18.6 Bat Medical Competitive Strengths & Weaknesses
8.1 Peripheral Vasodilator Drugs Industry Chain
8.2 Peripheral Vasodilator Drugs Upstream Analysis
8.2.1 Peripheral Vasodilator Drugs Core Raw Materials
8.2.2 Main Manufacturers of Peripheral Vasodilator Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Peripheral Vasodilator Drugs Production Mode
8.6 Peripheral Vasodilator Drugs Procurement Model
8.7 Peripheral Vasodilator Drugs Industry Sales Model and Sales Channels
8.7.1 Peripheral Vasodilator Drugs Sales Model
8.7.2 Peripheral Vasodilator Drugs Typical Distributors
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables Table 1. World Peripheral Vasodilator Drugs Production Value by Region (2020, 2024 and 2031) & (USD Million) Table 2. World Peripheral Vasodilator Drugs Production Value by Region (2020-2025) & (USD Million) Table 3. World Peripheral Vasodilator Drugs Production Value by Region (2026-2031) & (USD Million) Table 4. World Peripheral Vasodilator Drugs Production Value Market Share by Region (2020-2025) Table 5. World Peripheral Vasodilator Drugs Production Value Market Share by Region (2026-2031) Table 6. World Peripheral Vasodilator Drugs Production by Region (2020-2025) & (K Units) Table 7. World Peripheral Vasodilator Drugs Production by Region (2026-2031) & (K Units) Table 8. World Peripheral Vasodilator Drugs Production Market Share by Region (2020-2025) Table 9. World Peripheral Vasodilator Drugs Production Market Share by Region (2026-2031) Table 10. World Peripheral Vasodilator Drugs Average Price by Region (2020-2025) & (US$/Unit) Table 11. World Peripheral Vasodilator Drugs Average Price by Region (2026-2031) & (US$/Unit) Table 12. Peripheral Vasodilator Drugs Major Market Trends Table 13. World Peripheral Vasodilator Drugs Consumption Growth Rate Forecast by Region (2020 & 2024 & 2031) & (K Units) Table 14. World Peripheral Vasodilator Drugs Consumption by Region (2020-2025) & (K Units) Table 15. World Peripheral Vasodilator Drugs Consumption Forecast by Region (2026-2031) & (K Units) Table 16. World Peripheral Vasodilator Drugs Production Value by Manufacturer (2020-2025) & (USD Million) Table 17. Production Value Market Share of Key Peripheral Vasodilator Drugs Producers in 2024 Table 18. World Peripheral Vasodilator Drugs Production by Manufacturer (2020-2025) & (K Units) Table 19. Production Market Share of Key Peripheral Vasodilator Drugs Producers in 2024 Table 20. World Peripheral Vasodilator Drugs Average Price by Manufacturer (2020-2025) & (US$/Unit) Table 21. Global Peripheral Vasodilator Drugs Company Evaluation Quadrant Table 22. World Peripheral Vasodilator Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2024 Table 23. Head Office and Peripheral Vasodilator Drugs Production Site of Key Manufacturer Table 24. Peripheral Vasodilator Drugs Market: Company Product Type Footprint Table 25. Peripheral Vasodilator Drugs Market: Company Product Application Footprint Table 26. Peripheral Vasodilator Drugs Competitive Factors Table 27. Peripheral Vasodilator Drugs New Entrant and Capacity Expansion Plans Table 28. Peripheral Vasodilator Drugs Mergers & Acquisitions Activity Table 29. United States VS China Peripheral Vasodilator Drugs Production Value Comparison, (2020 & 2024 & 2031) & (USD Million) Table 30. United States VS China Peripheral Vasodilator Drugs Production Comparison, (2020 & 2024 & 2031) & (K Units) Table 31. United States VS China Peripheral Vasodilator Drugs Consumption Comparison, (2020 & 2024 & 2031) & (K Units) Table 32. United States Based Peripheral Vasodilator Drugs Manufacturers, Headquarters and Production Site (States, Country) Table 33. United States Based Manufacturers Peripheral Vasodilator Drugs Production Value, (2020-2025) & (USD Million) Table 34. United States Based Manufacturers Peripheral Vasodilator Drugs Production Value Market Share (2020-2025) Table 35. United States Based Manufacturers Peripheral Vasodilator Drugs Production (2020-2025) & (K Units) Table 36. United States Based Manufacturers Peripheral Vasodilator Drugs Production Market Share (2020-2025) Table 37. China Based Peripheral Vasodilator Drugs Manufacturers, Headquarters and Production Site (Province, Country) Table 38. China Based Manufacturers Peripheral Vasodilator Drugs Production Value, (2020-2025) & (USD Million) Table 39. China Based Manufacturers Peripheral Vasodilator Drugs Production Value Market Share (2020-2025) Table 40. China Based Manufacturers Peripheral Vasodilator Drugs Production, (2020-2025) & (K Units) Table 41. China Based Manufacturers Peripheral Vasodilator Drugs Production Market Share (2020-2025) Table 42. Rest of World Based Peripheral Vasodilator Drugs Manufacturers, Headquarters and Production Site (State, Country) Table 43. Rest of World Based Manufacturers Peripheral Vasodilator Drugs Production Value, (2020-2025) & (USD Million) Table 44. Rest of World Based Manufacturers Peripheral Vasodilator Drugs Production Value Market Share (2020-2025) Table 45. Rest of World Based Manufacturers Peripheral Vasodilator Drugs Production, (2020-2025) & (K Units) Table 46. Rest of World Based Manufacturers Peripheral Vasodilator Drugs Production Market Share (2020-2025) Table 47. World Peripheral Vasodilator Drugs Production Value by Type, (USD Million), 2020 & 2024 & 2031 Table 48. World Peripheral Vasodilator Drugs Production by Type (2020-2025) & (K Units) Table 49. World Peripheral Vasodilator Drugs Production by Type (2026-2031) & (K Units) Table 50. World Peripheral Vasodilator Drugs Production Value by Type (2020-2025) & (USD Million) Table 51. World Peripheral Vasodilator Drugs Production Value by Type (2026-2031) & (USD Million) Table 52. World Peripheral Vasodilator Drugs Average Price by Type (2020-2025) & (US$/Unit) Table 53. World Peripheral Vasodilator Drugs Average Price by Type (2026-2031) & (US$/Unit) Table 54. World Peripheral Vasodilator Drugs Production Value by Application, (USD Million), 2020 & 2024 & 2031 Table 55. World Peripheral Vasodilator Drugs Production by Application (2020-2025) & (K Units) Table 56. World Peripheral Vasodilator Drugs Production by Application (2026-2031) & (K Units) Table 57. World Peripheral Vasodilator Drugs Production Value by Application (2020-2025) & (USD Million) Table 58. World Peripheral Vasodilator Drugs Production Value by Application (2026-2031) & (USD Million) Table 59. World Peripheral Vasodilator Drugs Average Price by Application (2020-2025) & (US$/Unit) Table 60. World Peripheral Vasodilator Drugs Average Price by Application (2026-2031) & (US$/Unit) Table 61. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors Table 62. Pfizer, Inc. Major Business Table 63. Pfizer, Inc. Peripheral Vasodilator Drugs Product and Services Table 64. Pfizer, Inc. Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025) Table 65. Pfizer, Inc. Recent Developments/Updates Table 66. Pfizer, Inc. Competitive Strengths & Weaknesses Table 67. Novartis AG Basic Information, Manufacturing Base and Competitors Table 68. Novartis AG Major Business Table 69. Novartis AG Peripheral Vasodilator Drugs Product and Services Table 70. Novartis AG Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025) Table 71. Novartis AG Recent Developments/Updates Table 72. Novartis AG Competitive Strengths & Weaknesses Table 73. GSK plc Basic Information, Manufacturing Base and Competitors Table 74. GSK plc Major Business Table 75. GSK plc Peripheral Vasodilator Drugs Product and Services Table 76. GSK plc Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025) Table 77. GSK plc Recent Developments/Updates Table 78. GSK plc Competitive Strengths & Weaknesses Table 79. AstraZeneca Basic Information, Manufacturing Base and Competitors Table 80. AstraZeneca Major Business Table 81. AstraZeneca Peripheral Vasodilator Drugs Product and Services Table 82. AstraZeneca Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025) Table 83. AstraZeneca Recent Developments/Updates Table 84. AstraZeneca Competitive Strengths & Weaknesses Table 85. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors Table 86. Merck & Co., Inc. Major Business Table 87. Merck & Co., Inc. Peripheral Vasodilator Drugs Product and Services Table 88. Merck & Co., Inc. Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025) Table 89. Merck & Co., Inc. Recent Developments/Updates Table 90. Merck & Co., Inc. Competitive Strengths & Weaknesses Table 91. Sanofi Basic Information, Manufacturing Base and Competitors Table 92. Sanofi Major Business Table 93. Sanofi Peripheral Vasodilator Drugs Product and Services Table 94. Sanofi Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025) Table 95. Sanofi Recent Developments/Updates Table 96. Sanofi Competitive Strengths & Weaknesses Table 97. Bayer AG Basic Information, Manufacturing Base and Competitors Table 98. Bayer AG Major Business Table 99. Bayer AG Peripheral Vasodilator Drugs Product and Services Table 100. Bayer AG Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025) Table 101. Bayer AG Recent Developments/Updates Table 102. Bayer AG Competitive Strengths & Weaknesses Table 103. Abbott Laboratories Basic Information, Manufacturing Base and Competitors Table 104. Abbott Laboratories Major Business Table 105. Abbott Laboratories Peripheral Vasodilator Drugs Product and Services Table 106. Abbott Laboratories Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025) Table 107. Abbott Laboratories Recent Developments/Updates Table 108. Abbott Laboratories Competitive Strengths & Weaknesses Table 109. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors Table 110. Bristol-Myers Squibb Company Major Business Table 111. Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Product and Services Table 112. Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025) Table 113. Bristol-Myers Squibb Company Recent Developments/Updates Table 114. Bristol-Myers Squibb Company Competitive Strengths & Weaknesses Table 115. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors Table 116. Boehringer Ingelheim International GmbH Major Business Table 117. Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Product and Services Table 118. Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025) Table 119. Boehringer Ingelheim International GmbH Recent Developments/Updates Table 120. Boehringer Ingelheim International GmbH Competitive Strengths & Weaknesses Table 121. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors Table 122. Teva Pharmaceutical Industries Ltd. Major Business Table 123. Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product and Services Table 124. Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025) Table 125. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates Table 126. Teva Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses Table 127. Viatris, Inc. Basic Information, Manufacturing Base and Competitors Table 128. Viatris, Inc. Major Business Table 129. Viatris, Inc. Peripheral Vasodilator Drugs Product and Services Table 130. Viatris, Inc. Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025) Table 131. Viatris, Inc. Recent Developments/Updates Table 132. Viatris, Inc. Competitive Strengths & Weaknesses Table 133. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors Table 134. Sun Pharmaceutical Industries Ltd. Major Business Table 135. Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product and Services Table 136. Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025) Table 137. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates Table 138. Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses Table 139. Lupin Basic Information, Manufacturing Base and Competitors Table 140. Lupin Major Business Table 141. Lupin Peripheral Vasodilator Drugs Product and Services Table 142. Lupin Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025) Table 143. Lupin Recent Developments/Updates Table 144. Lupin Competitive Strengths & Weaknesses Table 145. Aotecar Medical-B Basic Information, Manufacturing Base and Competitors Table 146. Aotecar Medical-B Major Business Table 147. Aotecar Medical-B Peripheral Vasodilator Drugs Product and Services Table 148. Aotecar Medical-B Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025) Table 149. Aotecar Medical-B Recent Developments/Updates Table 150. Aotecar Medical-B Competitive Strengths & Weaknesses Table 151. Endovastec Basic Information, Manufacturing Base and Competitors Table 152. Endovastec Major Business Table 153. Endovastec Peripheral Vasodilator Drugs Product and Services Table 154. Endovastec Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025) Table 155. Endovastec Recent Developments/Updates Table 156. Endovastec Competitive Strengths & Weaknesses Table 157. Tibet Cheezheng Tibetan Medicine Co., Ltd Basic Information, Manufacturing Base and Competitors Table 158. Tibet Cheezheng Tibetan Medicine Co., Ltd Major Business Table 159. Tibet Cheezheng Tibetan Medicine Co., Ltd Peripheral Vasodilator Drugs Product and Services Table 160. Tibet Cheezheng Tibetan Medicine Co., Ltd Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025) Table 161. Tibet Cheezheng Tibetan Medicine Co., Ltd Recent Developments/Updates Table 162. Tibet Cheezheng Tibetan Medicine Co., Ltd Competitive Strengths & Weaknesses Table 163. Bat Medical Basic Information, Manufacturing Base and Competitors Table 164. Bat Medical Major Business Table 165. Bat Medical Peripheral Vasodilator Drugs Product and Services Table 166. Bat Medical Peripheral Vasodilator Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025) Table 167. Bat Medical Recent Developments/Updates Table 168. Bat Medical Competitive Strengths & Weaknesses Table 169. Global Key Players of Peripheral Vasodilator Drugs Upstream (Raw Materials) Table 170. Global Peripheral Vasodilator Drugs Typical Customers Table 171. Peripheral Vasodilator Drugs Typical Distributors List of Figures Figure 1. Peripheral Vasodilator Drugs Picture Figure 2. World Peripheral Vasodilator Drugs Production Value: 2020 & 2024 & 2031, (USD Million) Figure 3. World Peripheral Vasodilator Drugs Production Value and Forecast (2020-2031) & (USD Million) Figure 4. World Peripheral Vasodilator Drugs Production (2020-2031) & (K Units) Figure 5. World Peripheral Vasodilator Drugs Average Price (2020-2031) & (US$/Unit) Figure 6. World Peripheral Vasodilator Drugs Production Value Market Share by Region (2020-2031) Figure 7. World Peripheral Vasodilator Drugs Production Market Share by Region (2020-2031) Figure 8. North America Peripheral Vasodilator Drugs Production (2020-2031) & (K Units) Figure 9. Europe Peripheral Vasodilator Drugs Production (2020-2031) & (K Units) Figure 10. China Peripheral Vasodilator Drugs Production (2020-2031) & (K Units) Figure 11. Japan Peripheral Vasodilator Drugs Production (2020-2031) & (K Units) Figure 12. Peripheral Vasodilator Drugs Market Drivers Figure 13. Factors Affecting Demand Figure 14. World Peripheral Vasodilator Drugs Consumption (2020-2031) & (K Units) Figure 15. World Peripheral Vasodilator Drugs Consumption Market Share by Region (2020-2031) Figure 16. United States Peripheral Vasodilator Drugs Consumption (2020-2031) & (K Units) Figure 17. China Peripheral Vasodilator Drugs Consumption (2020-2031) & (K Units) Figure 18. Europe Peripheral Vasodilator Drugs Consumption (2020-2031) & (K Units) Figure 19. Japan Peripheral Vasodilator Drugs Consumption (2020-2031) & (K Units) Figure 20. South Korea Peripheral Vasodilator Drugs Consumption (2020-2031) & (K Units) Figure 21. ASEAN Peripheral Vasodilator Drugs Consumption (2020-2031) & (K Units) Figure 22. India Peripheral Vasodilator Drugs Consumption (2020-2031) & (K Units) Figure 23. Producer Shipments of Peripheral Vasodilator Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2024 Figure 24. Global Four-firm Concentration Ratios (CR4) for Peripheral Vasodilator Drugs Markets in 2024 Figure 25. Global Four-firm Concentration Ratios (CR8) for Peripheral Vasodilator Drugs Markets in 2024 Figure 26. United States VS China: Peripheral Vasodilator Drugs Production Value Market Share Comparison (2020 & 2024 & 2031) Figure 27. United States VS China: Peripheral Vasodilator Drugs Production Market Share Comparison (2020 & 2024 & 2031) Figure 28. United States VS China: Peripheral Vasodilator Drugs Consumption Market Share Comparison (2020 & 2024 & 2031) Figure 29. United States Based Manufacturers Peripheral Vasodilator Drugs Production Market Share 2024 Figure 30. China Based Manufacturers Peripheral Vasodilator Drugs Production Market Share 2024 Figure 31. Rest of World Based Manufacturers Peripheral Vasodilator Drugs Production Market Share 2024 Figure 32. World Peripheral Vasodilator Drugs Production Value by Type, (USD Million), 2020 & 2024 & 2031 Figure 33. World Peripheral Vasodilator Drugs Production Value Market Share by Type in 2024 Figure 34. Calcium Channel Blockers Figure 35. Alpha-adrenergic Blockers Figure 36. Potassium Channel Activators Figure 37. Others Figure 38. World Peripheral Vasodilator Drugs Production Market Share by Type (2020-2031) Figure 39. World Peripheral Vasodilator Drugs Production Value Market Share by Type (2020-2031) Figure 40. World Peripheral Vasodilator Drugs Average Price by Type (2020-2031) & (US$/Unit) Figure 41. World Peripheral Vasodilator Drugs Production Value by Application, (USD Million), 2020 & 2024 & 2031 Figure 42. World Peripheral Vasodilator Drugs Production Value Market Share by Application in 2024 Figure 43. Hospital Figure 44. Retail Pharmacies Figure 45. Others Figure 46. World Peripheral Vasodilator Drugs Production Market Share by Application (2020-2031) Figure 47. World Peripheral Vasodilator Drugs Production Value Market Share by Application (2020-2031) Figure 48. World Peripheral Vasodilator Drugs Average Price by Application (2020-2031) & (US$/Unit) Figure 49. Peripheral Vasodilator Drugs Industry Chain Figure 50. Peripheral Vasodilator Drugs Procurement Model Figure 51. Peripheral Vasodilator Drugs Sales Model Figure 52. Peripheral Vasodilator Drugs Sales Channels, Direct Sales, and Distribution Figure 53. Methodology Figure 54. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.
Validation and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Pfizer, Inc. Novartis AG GSK plc AstraZeneca Merck & Co., Inc. Sanofi Bayer AG Abbott Laboratories Bristol-Myers Squibb Company Boehringer Ingelheim International GmbH Teva Pharmaceutical Industries Ltd. Viatris, Inc. Sun Pharmaceutical Industries Ltd. Lupin Aotecar Medical-B Endovastec Tibet Cheezheng Tibetan Medicine Co., Ltd Bat Medical
Related Reports
4 Jul 2025
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
- Digging deeper into global industry information and providing market strategies.Contact Us >>
